BI
BioVie
BIVI·NASDAQCarson City NVFounded 201610 employees
Micro CapbiotechPublicNeurologyHepatology
Platform: NE3107 AD/NASH
Market Cap
$0.05B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (BIVI)
Loading BIVI stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lirainavolisib | BIV-7820 | Approved | 1 | ALK | CML | ||
| BIV-3779 | BIV-3779 | Phase 2/3 | 1 | IL-17A | MGFSGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)